Graham Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.9M Buy
150,910
+107,911
+251% +$2.13M 0.07% 207
2025
Q4
$814K Sell
42,999
-114,595
-73% -$2.12M 0.02% 445
2025
Q3
$2.94M Buy
157,594
+33,379
+27% +$623K 0.05% 170
2025
Q2
$2.29M Sell
124,215
-152,329
-55% -$2.7M 0.03% 331
2025
Q1
$4.83M Buy
276,544
+75,893
+38% +$1.28M 0.08% 141
2024
Q4
$3.48M Buy
200,651
+102,812
+105% +$1.88M 0.05% 186
2024
Q3
$1.82M Sell
97,839
-59,492
-38% -$1M 0.03% 300
2024
Q2
$2.42M Buy
+157,331
New +$2.25M 0.05% 209
2023
Q4
Sell
-99,830
Closed -$1.39M 1295
2023
Q3
$1.39M Buy
+99,830
New +$1.28M 0.03% 273
2022
Q4
Sell
-54,343
Closed -$712K 1309
2022
Q3
$712K Buy
+54,343
New +$803K 0.03% 623

Other funds holding SBRA

Graham Capital Management's SBRA Position: Q1 2026 in Review

Graham Capital Management increased its Sabra Healthcare REIT (SBRA) stake by 251% in Q1 2026, buying an estimated $2.13M and bringing the position to 150,910 shares worth $2.9M. The position accounts for 0.07% of the portfolio, ranked #207.

Graham Capital Management first reported a position in SBRA in Q3 2022 and has held it in 10 quarters since. The position peaked at $4.83M in Q1 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Graham Capital Management held 150,910 shares of Sabra Healthcare REIT worth $2.9M as of Q1 2026.
  • Graham Capital Management bought 107,911 Sabra Healthcare REIT shares in Q1 2026, an estimated $2.13M.
  • Sabra Healthcare REIT made up 0.07% of Graham Capital Management's portfolio in Q1 2026, its #207 holding.
  • Graham Capital Management first reported a position in Sabra Healthcare REIT in Q3 2022 and has held it in 10 quarters since.
  • Graham Capital Management's Sabra Healthcare REIT position peaked at $4.83M in Q1 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.